Molecular imaging in the management of cervical cancer

被引：9

作者：

Lai, Chyong-Huey ^{[1
]}

Yen, Tzu-Chen ^{[2
]}

Ng, Koon-Kwan ^{[3
]}

机构：

[1] Chang Gung Univ, Chang Gung Mem Hosp, Dept Obstet & Gynecol, Div Gynecol Oncol,Coll Med, Tao Yuan 333, Taiwan

[2] Chang Gung Univ, Chang Gung Mem Hosp, Coll Med, Dept Nucl Med, Tao Yuan 333, Taiwan

[3] Chang Gung Univ, Chang Gung Mem Hosp, Coll Med, Dept Med Imaging & Intervent, Tao Yuan 333, Taiwan

来源：

JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION | 2012年 / 111卷 / 08期

关键词：

cervical cancer; molecular imaging; MRI; PET; PET/CT; POSITRON-EMISSION-TOMOGRAPHY; LYMPH-NODE METASTASES; DIAGNOSTIC PERFORMANCE; COST-EFFECTIVENESS; F-18-FDG PET; CARCINOMA; PHASE; TRIAL; MRI; CT;

D O I：

10.1016/j.jfma.2012.02.024

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

Positron emission tomography (PET), magnetic resonance imaging (MRI), and integrated 18-fluorodeoxyglucose (F-18-FDG) PET/computed tomography are valuable techniques for assessing prognosis, treatment response after the completion of concurrent chemoradiation, suspicious or documented recurrence, unexplained post therapy elevations in tumor markers, and the response to salvage treatment when managing cervical cancer. However, PET plays a limited role in the primary staging of MRI-defined node-negative patients. Currently, F-18-FDG is still the only tracer approved for routine use, but several novel targeting PET compounds, high-Testa MRI machines, diffusion-weighted imaging without contrast, and dynamic nuclear polarized-enhanced C-13-MR spectroscopic imaging may hold promising applications. Copyright (C) 2012, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.

引用

页码：412 / 420

页数：9

共 66 条

[1]

[Anonymous], Clinical practice guidelines in oncology

[2]

Immuno-PET of Cancer: A Revival of Antibody Imaging [J].

Boerman, Otto C. ;

Oyen, Wim J. G. .

JOURNAL OF NUCLEAR MEDICINE, 2011, 52 (08) :1171-1172

[3]

The 68Ge/68Ga generator has high potential, but when can we use 68Ga-labelled tracers in clinical routine? [J].

Breeman, Wouter A. P. ;

Verbruggen, Alfons M. .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 (07) :978-981

[4]

124I-huA33 Antibody PET of Colorectal Cancer [J].

Carrasquillo, Jorge A. ;

Pandit-Taskar, Neeta ;

O'Donoghue, Joseph A. ;

Humm, John L. ;

Zanzonico, Pat ;

Smith-Jones, Peter M. ;

Divgi, Chaitanya R. ;

Pryma, Daniel A. ;

Ruan, Shutian ;

Kemeny, Nancy E. ;

Fong, Yuman ;

Wong, Douglas ;

Jaggi, Jaspreet S. ;

Scheinberg, David A. ;

Gonen, Mithat ;

Panageas, Katherine S. ;

Ritter, Gerd ;

Jungbluth, Achim A. ;

Old, Lloyd J. ;

Larson, Steven M. .

JOURNAL OF NUCLEAR MEDICINE, 2011, 52 (08) :1173-1180

[5]

Cost Effectiveness of Positron Emission Tomography in Patients With Hodgkin's Lymphoma in Unconfirmed Complete Remission or Partial Remission After First-Line Therapy [J].

Cerci, Juliano J. ;

Trindade, Evelinda ;

Pracchia, Luis F. ;

Pitella, Felipe A. ;

Linardi, Camila C. G. ;

Soares, Jose, Jr. ;

Delbeke, Dominique ;

Topfer, Leigh-Ann ;

Buccheri, Valeria ;

Meneghetti, Jose C. .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (08) :1415-1421

[6]

Positron emission tomography for unexplained elevation of serum squamous cell carcinoma antigen levels during follow-up for patients with cervical malignancies - A phase II study [J].

Chang, TC ;

Law, KS ;

Hong, JH ;

Lai, CH ;

Ng, KK ;

Hsueh, S ;

See, LC ;

Chang, YC ;

Tsai, CS ;

Chou, HH ;

Huang, KG ;

Liou, JD ;

Lin, CT ;

Chao, A ;

Chen, MY ;

Wu, TI ;

Ma, SY ;

Yen, TC .

CANCER, 2004, 101 (01) :164-171

[7]

Positron emission tomography in evaluating the feasibility of curative intent in cervical cancer patients with limited distant lymph node metastases [J].

Chao, Angel ;

Ho, Kung-Chu ;

Wang, Chun-Chieh ;

Cheng, Hui-Hsin ;

Lin, Gigin ;

Yen, Tzu-Chen ;

Lai, Chyong-Huey .

GYNECOLOGIC ONCOLOGY, 2008, 110 (02) :172-178

[8]

Endovaginal magnetic resonance imaging of stage 1A/1B cervical cancer with A T2- and diffusion-weighted magnetic resonance technique: Effect of lesion size and previous cone biopsy on tumor detectability [J].

Charles-Edwards, Elizabeth ;

Morgan, Veronica ;

Attygalle, Ayoma D. ;

Giles, Sharon L. ;

Ind, Thomas E. ;

Davis, Michael ;

Shepherd, John ;

McWhinney, Norman ;

deSouza, Nandita M. .

GYNECOLOGIC ONCOLOGY, 2011, 120 (03) :368-373

[9]

Chen JC., 1989, RADIOLOGY

[10]

Low value of [18F]-fluoro-2-deoxy-D-glucose positron emission tomography in primary staging of early-stage cervical cancer before radical hysterectomy [J].

Chou, HH ;

Chang, TC ;

Yen, TC ;

Ng, KK ;

Hsueh, S ;

Ma, SY ;

Chang, CJ ;

Huang, HJ ;

Chao, A ;

Wu, TI ;

Jung, SM ;

Wu, YC ;

Lin, CT ;

Huang, KG ;

Lai, CH .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (01) :123-128

← 1 2 3 4 5 6 7 →